DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 61 filers reported holding DESIGN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $18,718,755 | +9.2% | 2,971,231 | 0.0% | 0.35% | -9.0% |
| Q1 2023 | $17,144,003 | -43.8% | 2,971,231 | 0.0% | 0.39% | -37.2% |
| Q4 2022 | $30,484,830 | -34.3% | 2,971,231 | +7.1% | 0.62% | -37.5% |
| Q3 2022 | $46,368,000 | +51.5% | 2,773,231 | +26.8% | 0.99% | +21.2% |
| Q2 2022 | $30,613,000 | -13.3% | 2,186,636 | 0.0% | 0.82% | +5.8% |
| Q1 2022 | $35,314,000 | -24.6% | 2,186,636 | 0.0% | 0.77% | -6.5% |
| Q4 2021 | $46,816,000 | +45.7% | 2,186,636 | 0.0% | 0.82% | +85.4% |
| Q3 2021 | $32,122,000 | -26.1% | 2,186,636 | 0.0% | 0.44% | -36.2% |
| Q2 2021 | $43,492,000 | -33.5% | 2,186,636 | 0.0% | 0.70% | -29.2% |
| Q1 2021 | $65,380,000 | – | 2,186,636 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 5,364,850 | $78,810,000 | 3.20% |
| Logos Global Management LP | 2,772,501 | $40,728,000 | 2.94% |
| EcoR1 Capital, LLC | 1,863,098 | $27,369,000 | 0.95% |
| RA Capital Management | 2,186,636 | $32,122,000 | 0.44% |
| Vivo Capital, LLC | 530,991 | $7,800,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,468,318 | $21,570,000 | 0.34% |
| Artal Group S.A. | 400,000 | $5,876,000 | 0.13% |
| Rock Springs Capital Management LP | 334,050 | $4,907,000 | 0.10% |
| Baker Brothers Advisors | 1,436,636 | $21,104,000 | 0.09% |
| Eventide Asset Management | 400,000 | $5,876,000 | 0.08% |